
doi: 10.1056/nejmp1809358
pmid: 30207910
Limiting State Flexibility in Drug Pricing To reduce the burden of high-cost, low-value drugs, Massachusetts has proposed establishing a closed formulary, in which certain drugs can be excluded fro...
Drug Industry, Medicaid, United States Food and Drug Administration, Formularies as Topic, Centers for Medicare and Medicaid Services, U.S., Drug Costs, Insurance Coverage, United States, Massachusetts, Fees, Pharmaceutical, Government Regulation, Drug Approval, State Government
Drug Industry, Medicaid, United States Food and Drug Administration, Formularies as Topic, Centers for Medicare and Medicaid Services, U.S., Drug Costs, Insurance Coverage, United States, Massachusetts, Fees, Pharmaceutical, Government Regulation, Drug Approval, State Government
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
